Halozyme CEO Lim resigns

Halozyme Therapeutics Inc. (NASDAQ:HALO) said Jonathan Lim resigned as president, CEO and a director. He is replaced by VP and CSO Gregory Frost. The endocrine, cancer and dermatology company promoted...